M

Author

Marcus Chen

Markets & Equities Correspondent

Marcus Chen has covered global equity markets for 12 years, reporting on earnings season, stock listings, and corporate deal activity across US and Asian exchanges. He holds a CFA charter and previously worked as an equity research associate at a Singapore brokerage before moving into financial journalism. His reporting focuses on translating quarterly results and M&A activity into plain-language coverage for retail investors.

Covers:
  • stocks
  • markets
  • earnings
  • mergers-acquisitions
Latest by Marcus Chen
Wells Fargo Taps Annexon as Top Biotech Pick on Pipeline Potential

Stocks

Wells Fargo Taps Annexon as Top Biotech Pick on Pipeline Potential

Jul 21, 2026

Wells Fargo has named Annexon its top biotechnology stock, citing a significant upside potential of 7-8 times in its bull case. The firm's optimism is based on upcoming catalysts, including Phase 3 data for its geographic atrophy drug and a regulatory filing for its Guillain-Barré syndrome treatment.